Previous studies have thus evaluated the sensitivity, concordance, and reproducibility between NGS and the alternative technical approaches of EGFR genotyping, but whether the early genotyping of EGFR can initiate more quickly the treatment of patients with NSCLC is not clearly answered in the literature. This evidence concerns the gene EGFR and non-small cell lung carcinoma.